You can buy or sell HCM and other stocks, options, ETFs, and crypto commission-free!
Hutchison China MediTech Limited American Depositary Shares, also called Hutchison China Meditech, is a holding company, which engages in the research and development, manufactures, and sells pharmaceuticals and health oriented consumer products. It operates through the Innovation Platform and Commercial Platform segments. Read More The Innovation Platform segment relates to research and development of innovative therapeutics in oncology and autoimmune diseases. The Commercial Platform segment relates to prescription drugs which develops, manufacture, markets, and sale of prescription pharmaceuticals; and consumer health which comprised of development, manufacture, distribution, and marketing of over-the-counter pharmaceuticals, and consumer health products. The company was founded in June 2000 and is headquartered in Hong Kong.
Hong Kong, Central & Western
52 Week High
52 Week Low
Research And Development
Advertising and Marketing
Seeking AlphaMar 11
Hutchison China MediTech Ltd (HCM) CEO Christian Hogg on Q4 2018 Results - Earnings Call Transcript
Hutchison China MediTech Ltd (NASDAQ:HCM) Q4 2018 Earnings Conference Call March 11, 2019 4:00 AM ET Company Participants Christian Hogg - CEO & Executive Director Conference Call Participants Michael Mitchell - Panmure Gordon Cinney Zhang - Bloomberg Intelligence Susie Jana - Edison Investment Research Limited Christian Hogg Okay. All right. Well, 9:00. So thank you, everybody, for attending today the Hutchison China MediTech 2018 Results Presentation. As always, it's a very detailed presentation, ...